Numares seeks FDA nod for kidney function test

2020 01 16 18 27 4229 Kidney 400

Numares has submitted a 501(k) application to the U.S. Food and Drug Administration (FDA) for its new kidney function test, the Axinon glomerular filtration rate nuclear magnetic resonance platform.

In other news, Numares appointed Dr. Gregory Heath, the former general manager of diagnostics at Illumina, as a new member of its supervisory board. He will assist Numares in commercializing its multimarker-based diagnostic tests, including the kidney function test.

Page 1 of 164
Next Page